Dimethicone
Highest phase reached
Approved
Drug type
Unknown
- Listing at source
- Listed
- Highest phase reached
- Approved
- Drug type
- Unknown
- Drug name
- Dimethicone
- conotrane
- Conotrane
- cymex
- Cymex
- dimethicone component of simethicone
- Dimethicone component of simethicone
- hedrin
- Hedrin
- johnson s
- Johnson's
- rikospray
- Rikospray
- sentry dimethicone
- Sentry dimethicone
- siopel
- Siopel
- sprilon
- Sprilon
- superderm
- Superderm
- vasogen
- Vasogen
- dimethicone
- Dimethicone
- dimethicone 360
- Dimethicone 360
- dimethicone medical fluid 360
- Dimethicone medical fluid 360
- dimethicone unspecified
- Dimethicone, unspecified
- dimethicones
- Dimethicones
- dimethyl polysiloxane
- Dimethyl polysiloxane
- dimethylpolysiloxane
- Dimethylpolysiloxane
- dimethylsilicone fluid
- Dimethylsilicone fluid
- dimeticona
- Dimeticona
- dimeticone
- Dimeticone
- dimeticone 360
- Dimeticone-360
- e 900a
- E-900A
- ins 900a
And 9 more, listed on the interactive page.
- ATC classification codes
- P03AX05
Sources for recorded values
- ChEMBL ID
- CHEMBL2108200
- RxNorm IDs (RxCUI)
- 324072
- First in class
- No
- Orphan designation
- No
- Condition
- Diaper Rash
- Highest recorded phase
- 4
- Subject identifier
- D003963
- Condition
- Lacerations
- Highest recorded phase
- 4
- Subject identifier
- D022125
- Condition
- Psoriasis
- Highest recorded phase
- 2
- Condition identifier
- EFO:0000676
- Subject identifier
- D011565
- Condition
- Ectoparasitic Infestations
- Highest recorded phase
- 4
- Condition identifier
- EFO:0001067
- Subject identifier
- D004478
- Condition
- Sunburn
- Highest recorded phase
- 4
- Condition identifier
- EFO:0003958
- Subject identifier
- D013471
- Condition
- Pruritus
- Highest recorded phase
- 4
- Condition identifier
- HP:0000989
- Subject identifier
- D011537
- Condition
- Dermatitis
- Highest recorded phase
- 4
- Condition identifier
- MONDO:0002406
- Subject identifier
- D003872
- Condition
- Skin Neoplasms
- Highest recorded phase
- 4
- Condition identifier
- MONDO:0002898
- Subject identifier
- D012878
- Condition
- Ulcer
- Highest recorded phase
- 4
- Condition identifier
- MONDO:0043839
- Subject identifier
- D014456
- Condition identifier
- EFO_0000676
- Highest recorded phase
- 2
- Condition identifier
- EFO_0001067
- Condition identifier
- EFO_0003958
- Condition identifier
- HP_0000989
- Condition identifier
- HP_0000989
- Highest recorded phase
- 4
- Condition identifier
- MONDO_0002406
- Condition identifier
- MONDO_0002406
- Highest recorded phase
- 4
- Condition identifier
- MONDO_0002898
- Condition identifier
- MONDO_0002898
- Highest recorded phase
- 4
- Condition identifier
- MONDO_0003472
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0005135
- Highest recorded phase
- 4
- Condition identifier
- MONDO_0005326
- Highest recorded phase
- 4
- Condition identifier
- MONDO_0043839
- Condition identifier
- MONDO_0043839
- Highest recorded phase
- 4
- Event
- 5-hydroxyindolacetic acid in urine increased
- Reports
- 12
- Reporting signal score
- 65.681
- Event
- abdominal discomfort
- Reports
- 89
- Reporting signal score
- 64.9245
- Event
- abdominal pain
- Reports
- 138
- Reporting signal score
- 65.3344
- Event
- acute kidney injury
- Reports
- 95
- Reporting signal score
- 42.3306
- Event
- asthma
- Reports
- 95
- Reporting signal score
- 101.892
- Event
- blood mercury abnormal
- Reports
- 12
- Reporting signal score
- 68.748
- Event
- calciphylaxis
- Reports
- 34
- Reporting signal score
- 111.656
- Event
- cerebrovascular accident
- Reports
- 87
- Reporting signal score
- 44.1739
- Event
- coma
- Reports
- 205
- Reporting signal score
- 437.607
- Event
- confusional state
- Reports
- 94
- Reporting signal score
- 47.0007
- Event
- constipation
- Reports
- 169
- Reporting signal score
- 147.305
- Event
- dehydration
- Reports
- 85
- Reporting signal score
- 43.1371
- Event
- diarrhoea
- Reports
- 284
- Reporting signal score
- 107.666
- Event
- drug abuse
- Reports
- 60
- Reporting signal score
- 47.2084
- Event
- electrocardiogram qt prolonged
- Reports
- 52
- Reporting signal score
- 44.3049
- Event
- full blood count abnormal
- Reports
- 21
- Reporting signal score
- 51.958
- Event
- gastrooesophageal reflux disease
- Reports
- 239
- Reporting signal score
- 517.236
- Event
- glossodynia
- Reports
- 46
- Reporting signal score
- 84.1987
- Event
- hair follicle tumour benign
- Reports
- 9
- Reporting signal score
- 41.526
- Event
- hand deformity
- Reports
- 32
- Reporting signal score
- 60.0071
- Event
- head banging
- Reports
- 12
- Reporting signal score
- 46.4418
- Event
- hypercalcaemia
- Reports
- 158
- Reporting signal score
- 462.603
- Event
- hypocalcaemia
- Reports
- 46
- Reporting signal score
- 59.0917
- Event
- intestinal obstruction
- Reports
- 41
- Reporting signal score
- 45.8322
- Event
- liver injury
- Reports
- 60
- Reporting signal score
- 107.419
And 28 more, listed on the interactive page.
Trial references
- NCT01914627
- Prodrug
- No
- Chirality
- Single enantiomer
- Inorganic
- No
- Natural product
- No
Related records
Trials (3)
- Effect of Premedication With Pronase on Mucosal Cleanliness During EGD
- Efficacy and Safety of OsrhCT and Dimethicone Emulsion Before Upper Endoscopy on Visualization of the Gastric Mucosa.
- Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis
Approved for (5)
- Dermatitis
- Parasitic infectious disease
- Skin cancer
- Sunburn
- Ulcer disease
In development for (1)
- Psoriasis Phase 2